Portal Access, a medical device start-up company pioneering next-generation advanced vascular access solutions for oncology, announced the successful closing of a $7 million Series A financing round. The round was fully subscribed, reflecting strong investor support for the company's vision and technology.

Over 80% of the round was led by U.S physician investors including oncologists, interventional radiologists, cardiologists, vascular surgeons and others, in addition to a partnership from a U.S based venture capital fund; underscoring strong clinical conviction and belief in the device's potential to modernize cancer care drug delivery.